Leivaditis Vasileios, Maniatopoulos Andreas Antonios, Lausberg Henning, Mulita Francesk, Papatriantafyllou Athanasios, Liolis Elias, Beltsios Eleftherios, Adamou Antonis, Kontodimopoulos Nikolaos, Dahm Manfred
Department of Cardiothoracic and Vascular Surgery, Westpfalz Klinikum, 67655 Kaiserslautern, Germany.
Department of Electrical and Computer Engineering, Democritus University of Thrace, 67100 Xanthi, Greece.
J Clin Med. 2025 Apr 16;14(8):2729. doi: 10.3390/jcm14082729.
Artificial intelligence (AI) is rapidly transforming thoracic surgery by enhancing diagnostic accuracy, surgical precision, intraoperative guidance, and postoperative management. AI-driven technologies, including machine learning (ML), deep learning, computer vision, and robotic-assisted surgery, have the potential to optimize clinical workflows and improve patient outcomes. However, challenges such as data integration, ethical concerns, and regulatory barriers must be addressed to ensure AI's safe and effective implementation. This review aims to analyze the current applications, benefits, limitations, and future directions of AI in thoracic surgery. This review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was performed using PubMed, Scopus, Web of Science, and Cochrane Library for studies published up to January 2025. Relevant articles were selected based on predefined inclusion and exclusion criteria, focusing on AI applications in thoracic surgery, including diagnostics, robotic-assisted surgery, intraoperative guidance, and postoperative care. A risk of bias assessment was conducted using the Cochrane Risk of Bias Tool and ROBINS-I for non-randomized studies. Out of 279 identified studies, 36 met the inclusion criteria for qualitative synthesis, highlighting AI's growing role in diagnostic accuracy, surgical precision, intraoperative guidance, and postoperative care in thoracic surgery. AI-driven imaging analysis and radiomics have improved pulmonary nodule detection, lung cancer classification, and lymph node metastasis prediction, while robotic-assisted thoracic surgery (RATS) has enhanced surgical accuracy, reduced operative times, and improved recovery rates. Intraoperatively, AI-powered image-guided navigation, augmented reality (AR), and real-time decision-support systems have optimized surgical planning and safety. Postoperatively, AI-driven predictive models and wearable monitoring devices have enabled early complication detection and improved patient follow-up. However, challenges remain, including algorithmic biases, a lack of multicenter validation, high implementation costs, and ethical concerns regarding data security and clinical accountability. Despite these limitations, AI has shown significant potential to enhance surgical outcomes, requiring further research and standardized validation for widespread adoption. AI is poised to revolutionize thoracic surgery by enhancing decision-making, improving patient outcomes, and optimizing surgical workflows. However, widespread adoption requires addressing key limitations through multicenter validation studies, standardized AI frameworks, and ethical AI governance. Future research should focus on digital twin technology, federated learning, and explainable AI (XAI) to improve AI interpretability, reliability, and accessibility. With continued advancements and responsible integration, AI will play a pivotal role in shaping the next generation of precision thoracic surgery.
人工智能(AI)正在通过提高诊断准确性、手术精度、术中引导和术后管理,迅速改变胸外科手术。包括机器学习(ML)、深度学习、计算机视觉和机器人辅助手术在内的人工智能驱动技术,有潜力优化临床工作流程并改善患者预后。然而,必须解决诸如数据整合、伦理问题和监管障碍等挑战,以确保人工智能的安全有效实施。本综述旨在分析人工智能在胸外科手术中的当前应用、益处、局限性和未来方向。本综述按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行。使用PubMed、Scopus、Web of Science和Cochrane图书馆对截至2025年1月发表的研究进行了全面的文献检索。根据预先确定的纳入和排除标准选择相关文章,重点关注人工智能在胸外科手术中的应用,包括诊断、机器人辅助手术、术中引导和术后护理。使用Cochrane偏倚风险工具和ROBINS-I对非随机研究进行偏倚风险评估。在279项已识别的研究中,36项符合定性综合的纳入标准,突出了人工智能在胸外科手术的诊断准确性、手术精度、术中引导和术后护理中日益重要的作用。人工智能驱动的成像分析和放射组学改善了肺结节检测、肺癌分类和淋巴结转移预测,而机器人辅助胸外科手术(RATS)提高了手术准确性,缩短了手术时间,并提高了恢复率。在术中,人工智能驱动的图像引导导航、增强现实(AR)和实时决策支持系统优化了手术规划和安全性。术后,人工智能驱动的预测模型和可穿戴监测设备能够早期发现并发症并改善患者随访。然而,挑战依然存在,包括算法偏差、缺乏多中心验证、高实施成本以及数据安全和临床问责方面的伦理问题。尽管存在这些局限性,人工智能已显示出显著的提高手术效果的潜力,需要进一步研究和标准化验证以实现广泛应用。人工智能有望通过增强决策制定、改善患者预后和优化手术工作流程来彻底改变胸外科手术。然而,广泛应用需要通过多中心验证研究、标准化人工智能框架和符合伦理的人工智能治理来解决关键局限性。未来的研究应侧重于数字孪生技术、联邦学习和可解释人工智能(XAI),以提高人工智能的可解释性、可靠性和可及性。随着持续进步和负责任的整合,人工智能将在塑造下一代精准胸外科手术中发挥关键作用。